BioMarin Pharmaceutical, Inc. (BMRN)
Q2 2012 Earnings Call
August 1, 2012 05:00 pm ET
J. J. Bienaime – Chief Executive Officer
Hank Fuchs – Executive Vice President & Chief Medical Officer
Steve Aselage – Executive Vice President & Chief Business Officer
Eugenia Shen – Investor Relations
Analysts Mike Yee – RBC Capital Markets Salveen Richter – Canaccord Genuity Yaron Werber – Citi Chris Raymond – Robert W. Baird Matt Lowe – JP Morgan Joseph Schwartz – Leerink Swann Phil Nadeau – Cowen & Co. Alethia Young – Deutsche Bank Tim Lugo – William Blair & Company Ian Somaiya – Piper Jaffray Matthew Harrison – UBS Liana Moussatos – Wedbush Morgan Kim Lee – ThinkEquity Brian Abrams – Wells Fargo Securities Stephen Willey – Stifel Nicolaus
Previous Statements by BMRN
» BioMarin Pharmaceutical's CEO Discusses Q1 2012 Results - Earnings Call Transcript
» BioMarin Pharmaceutical's CEO Discusses Q4 2011 Earning Results - Earnings Call Transcript
» BioMarin Pharmaceutical Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)
» BioMarin Pharmaceutical's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV